UK markets close in 3 hours 38 minutes

Cogent Biosciences, Inc. (COGT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.50-0.30 (-3.41%)
At close: 04:00PM EDT
8.50 0.00 (0.00%)
After hours: 04:18PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
7,871
-
Operating expenses
Research development
105,399
173,755
121,627
55,913
25,738
-
Selling general and administrative
24,335
34,375
26,212
19,638
17,422
-
Total operating expenses
129,734
208,130
147,839
75,551
43,160
-
Operating income or loss
-129,734
-208,130
-147,839
-75,551
-35,289
-
Total other income/expenses net
2,213
2,643
3,609
2,811
-39,663
-
Income before tax
-125,535
-192,410
-140,241
-72,273
-74,808
-
Income from continuing operations
-125,535
-192,410
-140,241
-72,273
-74,808
-
Net income
-125,535
-192,410
-140,241
-72,273
-74,808
-
Net income available to common shareholders
-125,535
-192,410
-140,241
-72,273
-179,208
-
Basic EPS
-2.34
-
-2.39
-1.65
-16.17
-4.18
Diluted EPS
-2.34
-
-2.39
-1.65
-16.17
-4.18
Basic average shares
75,611
-
58,740
43,806
11,081
7,620
Diluted average shares
75,611
-
58,740
43,806
11,081
7,620